Events

Pipeline for Life: Revitalizing Our Biomedical Research Ecosystem for a Healthier Tomorrow

The Salk Institute, La Jolla, CA

CHI’s Pipeline for Life will focus on what can be done to support biomedical research in academic laboratories in the face of declining NIH funding. This program will explore the strategies and initiatives that academic institutions could use to broaden and enhance biomedical research efforts and how academic and industrial partners can work together to ensure robust pipelines through corporate deal transactions, and what the biomedical community can do to support federal funding for science. Collaboration between industry and academic partners will be necessary to keep the biomedical ecosystem healthy, and the industry’s pipeline full of innovation.

 

This year, our speakers will explore: the importance of federal funding to academic research programs; how academic and industrial partners can work together to ensure robust pipelines through corporate deal transactions, and what the biomedical community can do to encourage federal funding of science.

 Program Agenda

Time Session Title
11:30 – noon Registration
12:00 – 12:10 p.m. Welcoming Remarks: Paul Roben, Ph.D., Senior Director,Salk Institute
12:10 – 12:15 p.m. Remarks: Rep. Scott Peters, California’s 52nd Congressional District
12:20 – 1:10 p.m. Welcome Lunch: Modernizing the Research Model

  • Michael Friedman, M.D., CEO, City of Hope
1:15 – 2:15 p.m. Research Success: Balancing the Scale of Governmental Funds and Corporate Partnerships At a time when corporations are cutting internal R&D budgets, and governmental funding is at a historical low, it would be to the advantage of all for research institutions to partner with corporations in support of research programs. This panel will discuss the mix of government funding and corporate research funding agreements that have been used to help basic research flourish.

  • Moderator: David Gollaher, Ph.D., President & CEO, CHI
  • R. Sanders Williams, M.D., President, J. Gladstone Institutes
  • John Martin, Ph.D., Chairman of the Board and CEO, Gilead Sciences
  • *NEW* Nils Lonberg, Ph.D., Senior Vice President, Biologics Discovery California, Bristol-Myers Squibb
2:15 – 3:00 p.m. The Promise of Stem Cell Research: Advancing Our Future

  • Larry Goldstein, Ph.D., Director, UC San Diego Stem Cell Program
3:00 – 3:15 p.m. Coffee Break
3:15 – 4:15 p.m. Research in the 21st Century

  • Moderator: David Gollaher, Ph.D., President & CEO, CHI
  • Shlomo Melmed, M.B., Ch.B., M.A.C.P., F.R.C.P., Senior Vice President, Academic Affairs, Dean of the Medical Faculty, Helene A. and Philip E. Hixon Chair in Investigative Medicine, Cedars-Sinai
  • *NEW* Michael Drake, M.D., Chancellor, University of California, Irvine
  • Richard Gregory, Ph.D., Head of Research and Development, Genzyme
4:15 – 5:00 p.m. Basic Research and Public Policy: The Road Ahead The final panel of the day will discuss policies that could support basic research, and what the industry can do to support the legislation behind these policies.

  • Marc Tremblay, Ph.D.,  President, Clinical Diagnostics Division, Thermo Fisher Scientific
  • Michael Marletta, Ph.D., President and CEO, The Scripps Research Institute
5:00 p.m. Closing Remarks

  • David Pyott, Chairman, President & CEO, Allergan
5:00 – 6:00 p.m. Reception


Hotel Information

The Lodge at Torrey Pines
11480 N Torrey Pines Rd
La Jolla CA 92037
Reservation line: 858-453-4420
Group Name: CHI – California Healthcare Institute
Room rate (based on availability): $295++

Note: All individual reservations must be guaranteed with a major credit card and should be received by the Hotel no later than Friday, June 14, 2013. After the due date, if a guaranteed room is not canceled 72 hours prior to arrival, payment equal to one night room and tax will be charged.

Questions? Please contact CHI’s marketing and communications coordinator, Will Zasadny (858-456-8881 or Zasadny@chi.org).

Time Session Title
11:30 – noon Registration
12:00 – 12:10 p.m. Welcoming Remarks: Paul Roben, Ph.D., Senior Director, Office of Technology Development, Salk Institute for Biological Studies
12:10 – 12:15 p.m. Remarks: Rep. Scott Peters, California’s 52nd Congressional District
12:20 – 1:10 p.m. Welcome Lunch: Modernizing the Research Model

  • Michael Friedman, M.D., CEO, City of Hope
1:15 – 2:15 p.m. Research Success: Balancing the Scale of Governmental Funds and Corporate Partnerships At a time when corporations are cutting internal R&D budgets, and governmental funding is at a historical low, it would be to the advantage of all for research institutions to partner with corporations in support of research programs. This panel will discuss the mix of government funding and corporate research funding agreements that have been used to help basic research flourish.

  • Moderator: David Gollaher, Ph.D., President & CEO, CHI
  • R. Sanders Williams, M.D., President, J. Gladstone Institutes
  • John Martin, Ph.D., Chairman of the Board and CEO, Gilead Sciences
  • *NEW* Nils Lonberg, Ph.D., Senior Vice President, Biologics Discovery California, Bristol-Myers Squibb
2:15 – 3:00 p.m. The Promise of Stem Cell Research: Advancing Our Future

  • Larry Goldstein, Ph.D., Director, UC San Diego Stem Cell Program
3:00 – 3:15 p.m. Coffee Break
3:15 – 4:15 p.m. Research in the 21st Century

  • Moderator: David Gollaher, Ph.D., President & CEO, CHI
  • Shlomo Melmed, M.B., Ch.B., M.A.C.P., F.R.C.P., Senior Vice President, Academic Affairs, Dean of the Medical Faculty, Helene A. and Philip E. Hixon Chair in Investigative Medicine, Cedars-Sinai
  • *NEW * Michael Drake, M.D., Chancellor, University of California, Irvine
  • Richard Gregory, Ph.D., Head of Research and Development, Genzyme
4:15 – 5:00 p.m. Basic Research and Public Policy: The Road Ahead The final panel of the day will discuss policies that could support basic research, and what the industry can do to support the legislation behind these policies.

  • Marc Tremblay, Ph.D.,  President, Clinical Diagnostics Division, Thermo Fisher Scientific
  • Michael Marletta, Ph.D., President and CEO, The Scripps Research Institute
5:00 p.m. Closing Remarks

  • David Pyott, Chairman, President & CEO, Allergan
5:10 – 6:00 p.m. Reception

Membership Category

Early Bird Pricing

(Until June 7)

Pricing

Emerging Enterprise,
Non-Profit and Academic

$39

$49

CHI Member

$79

$99

Non-CHI member

$179

$199

 

 

 

 

Speakers and Panel Discussions

Research Success: Balancing the Scale of Governmental Funds and Corporate Partnerships

• Moderator: David Gollaher, Ph.D., President & CEO, CHI

Sandy Williams, M.D., President, J. Gladstone Institutes

John Martin, Ph.D., Chairman of the Board and CEO, Gilead Sciences

• *NEW* Nils Lonberg, Ph.D., Senior Vice President, Biologics Discovery California, Bristol-Myers Squibb

 

The Promise of Stem Cell Research: Advancing Our Future

Larry Goldstein, Ph.D., Director, UC San Diego Stem Cell Program

 

Research in the 21st Century

Moderator: David Gollaher, Ph.D., President & CEO, CHI

Shlomo Melmed, M.B., Ch.B., M.A.C.P., F.R.C.P., Senior Vice President, Academic Affairs, Dean of the Medical Faculty, Helene A. and Philip E. Hixon Chair in Investigative Medicine, Cedars-Sinai

*NEW* Michael Drake, M.D., Chancellor, University of California, Irvine

Richard Gregory, Ph.D., Head of Research and Development, Genzyme

 

Basic Research and Public Policy: The Road Ahead
Marc Tremblay, Ph.D.,  President, Clinical Diagnostics Division, Thermo Fisher Scientific

Michael Marletta, Ph.D., President and CEO, The Scripps Research Institute